“If the company sells medicine at a relatively lower price, it will greatly benefit the population”
“After the second half of January, we will have the ability to monitor the activities of Humanity Georgia on the Georgian pharmaceutical market,”– the Minister of Health of Georgia, David Sergeenko, said in a statement. As the Minister noted, the company began an active information campaign, explaining their intent.
“I will emphasize one thing, our strategy, which was aimed at increasing the accessibility on medicine, wasn’t for meant to lobby one specific company, Humanity for example, in any way. As far as we’ve seen and observed, this company began an active information campaign, explaining their intent, their ways of making these steps, and I think that after the second half of January we will have the ability to monitor the activities of this company. If as a result of their activities we see a drop in medicine prices through the rise of rivalry, we will, of course, only welcome that, without staying in a passive observing mode.”– stated Sergeenko. At the end, the department head noted that the Ministry of Health is changing and improving the system of making drug control stricter.
Nana Geladze, a children’s neuropathologist, made a comment regarding the Ministry’s initiative, the growth of strict conditions for medicine quality control and new players on the pharmaceutical field:
“My general prerogative is anti-epilepsy drugs. I end up prescribing them since my patients are children diagnosed with epilepsy. These drugs are mostly of French or German make, very famous brands. I’ve never personally prescribed local or other kinds of medicine. Not because they’d be necessarily bad, but because I hold a certain trust for specific drugs and I don’t want to run experiments. The initiative itself for the Health Ministry to recognize the low level of drug quality control in the country and make it stricter is very good. However, I’m left with the question of whether or not we have the necessary material resource to actually facilitate drug control in high-profile laboratories.”
As for new players on the pharmaceutical field, the doctor welcomes them.
“Usually, it should be an opportunity to raise the competition. I haven’t heard of “Humanity Georgia” specifically. If they will sell medicine for a relatively lower price, it will greatly benefit the population,” – explained Nana Geladze.
She also touched on the reforms that the Ministry has been carrying out recently, noting that insurance for all is one of the most successful and needed changes: “Free surgeries are a serious aid. I’m liking a lot of what their team’s doing.”
As a reminder, the Humanity Georgia company is currently entering the Georgian market. According to the company’s director, Andrei Kuzma, Humanity Georgia will offer a wide range of medical supplies to the Georgian pharmaceutical market in the nearest future. The company claims that the first wave of their medicine will be represented by drugs that are used more often, and will enter Georgia as soon as at the end of December. According to Kuzma, the quality of their drugs are confirmed by the EU GMP certificate and the serial control check carried out by a World Health Organization certificate-owning laboratory. The arrival of a new pharmaceutical company is positively viewed on by specialist, medical experts and politicians, explaining that this fact will benefit competition on the country’s pharmaceutical field, making medicine more accessible.